Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 144 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal Cancer Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell Lung Cancer MOST POPULAR Inequalities cause 2,000 extra cancer cases in Wales June 8, 2023 Trial Should Change Care for AIDS-Related Kaposi Sarcoma in Sub-Saharan Africa March 10, 2020 11 Children Orphaned and Unable to Pay for Funeral After Their... April 25, 2019 First-Line Serplulimab in Combination with Chemotherapy Improves Survival in Patients with... February 14, 2023 Load more HOT NEWS Contraception and cancer – a look behind the headlines Virtual Reality Could Reduce Stress for Chemo Patients, Improving Cancer Outcomes FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma Maintenance Therapy Delays Cancer Growth for People With Advanced or Recurrent...
